Biological treatment for industrial and municipal wastewaters.

Newlisi is the developer and provider of a proprietary technology process that disaggregates sludge coming from wastewater after primary and secondary biological treatment for industrial and municipal customers. The technology uses a multi-stage chemical process to break down sludge into an eluate, water and carbon dioxide. The eluate is then recycled through the biological treatment process of the main wastewater plant to eliminate the sludge, making this a zero sludge process. Newlisi is based in Milan, Italy and was founded in 2011.

Antonio Capristo, CEO of Newlisi, commented “GP Bullhound’s domain expertise and relationships in the water sector were instrumental in the negotiation and execution of this transaction. Our disruptive technology combined with their experience and dedication resulted in a highly competitive process and a successful transaction for all parties.”

Diana Saraceni, General Partner of 360 Capital, added “We are very excited to welcome Beautiful Mind Capital as a co-investor in Newlisi as we build out our industrial and municipal applications. Our core technology answers very pressing demand both in Europe and in China and we look forward to accelerated growth.”

Vivian Wang, Founding Partner of Beautiful Mind Capital, commented “We believe Newlisi’s unique technology meets fast growing demand for sludge treatment in China. We are committed to helping Newlisi with its planned expansion in China by leveraging Beautiful Mind Capital’s wide network in China.”